White Papers
Advancing Analytical Excellence Through Proactive Method Monitoring
Move from Reactive Investigations to Proactive Method Control
Transforming Laboratory Data into Actionable Insights with Waters Data Intelligence Software
Discover how Waters Data Intelligence Software can help laboratories unlock deeper insights from their Empower Software data
Spotlight on Cell and Gene Therapy: Advancing Manufacturing Towards Industry 4.0
Discover how smart bioprocessing, digital integration, and automation can help unlock the next phase of cell and gene therapy manufacturing
Advancing Oral Drug Delivery with Enprotect ®
What if enteric protection could be built directly into the capsule
AI-ENABLED PHARMACEUTICAL COCRYSTAL SCREENING
This white paper from Lonza and the American Chemical Society explains how AI-enabled cocrystal screening can help pharmaceutical companies identify promising solid forms of APIs earlier.
AI- and Model-Based Tools to Streamline Drug Development
This Lonza resource explains how AI, high-throughput experimentation (HTE), and model-based tools can streamline small-molecule drug development.
Bringing novel ADC formats into the clinic
This white paper from Lonza explains how next-generation antibody-drug conjugates (ADCs), especially antibody-oligonucleotide conjugates (AOCs), are expanding bioconjugate
Advancing ADCs: From concept to commercialization
This Lonza white paper explains how ADC development has evolved and how end-to-end technologies and manufacturing capabilities can help accelerate ADCs from concept to commercialization.
From Discovery to Patients: an Integrated Service for ADC Development by Lonza and Synaffix
This Lonza white paper explains how Synaffix technology and Lonza’s integrated ADC development services can help drug developers move antibody-drug conjugates (ADCs
A Scalable Primary Cell-Based 3D Human Skin Organoid Platform
Advance barrier biology and dermatotoxicology research with a scalable, primary cell-based 3D human skin organoid platform.
